Deng Mi
mideng@bjmu.edu.cn
English, Chinese
Beijing
Peking University
Basic Medical Sciences
  • 2007–2012 PhD: University of Nebraska Medical Center
  • 2012–2015 Postdoctoral Researcher: University of Texas Southwestern Medical Center
  • 2015–2017 - University of Texas Southwestern Medical Center - Lecturer
  • 2017–2020 - University of Texas Southwestern Medical Center - Assistant Professor
  • 2020–Present - Peking University Cancer Hospital - Researcher
Tumor Immunology
  • LILRB4, an immune checkpoint on myeloid cells, Yang T, Qian Y, Liang X, Wu J, Zou M, Deng M, 2022
  • LILRB3 supports acute myeloid leukemia development and regulates T cell anti-tumor immune responses through the TRAF2-cFLIP-NF-kB signaling axis, Wu G, Xu Y, Schultz R, Chen H, Xie J, Deng M, Liu X, Gui X, John S, Lu Z, Arase H, Zhang N, An Z, Zhang CC, 2021
Tumor Immunology Immune Cells Cancer Cells Molecular Mechanisms Cell Biology High-Throughput Omics Humanized Animal Models Immunotherapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.